# Spruce Power Holding Corp: financial statements, quarterly

SPRU · NYSE · CIK 1772720 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spru.md) · [Financials](/companies/spru/financials.md) · [Filings](/companies/spru/filings.md) · [Insiders](/companies/spru/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spru/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.3](/filings/0001628280-24-047866.md) | [15.7 d](/filings/0001628280-25-015702.md) | [18.3](/filings/0001628280-25-025590.md) | [22.5](/filings/0001628280-25-039904.md) | [21.4](/filings/0001628280-25-051737.md) | [20.2 d](/filings/0001628280-26-049579.md) | [23.8](/filings/0001628280-26-035176.md) | [33.3](/filings/0001628280-26-056824.md) | [30.7](/filings/0001628280-25-051737.md) | [24.0 d](/filings/0001628280-26-049579.md) | [23.4](/filings/0001628280-26-035176.md) | [30.3](/filings/0001628280-26-056824.md) |
| Cost of revenue | $m | [9.8](/filings/0001628280-23-038677.md) | [11.6 d](/filings/0001628280-24-015334.md) | [8.9](/filings/0001628280-24-023626.md) | [10.1](/filings/0001628280-24-037238.md) | [9.7](/filings/0001628280-24-047866.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [12.4](/filings/0001628280-24-047866.md) | [12.0 d](/filings/0001628280-25-015702.md) | [13.5](/filings/0001628280-25-025590.md) | [16.7](/filings/0001628280-25-039904.md) | [13.5](/filings/0001628280-25-051737.md) | [15.5 d](/filings/0001628280-26-049579.md) | [14.7](/filings/0001628280-26-035176.md) | [15.2](/filings/0001628280-26-056824.md) | [12.9](/filings/0001628280-25-051737.md) | [13.0 d](/filings/0001628280-26-049579.md) | [11.6](/filings/0001628280-26-035176.md) | [11.3](/filings/0001628280-26-056824.md) |
| Operating income | $m | [(24.5)](/filings/0001628280-24-047866.md) | [(8.5) d](/filings/0001628280-25-015702.md) | [(3.6)](/filings/0001628280-25-025590.md) | [(3.4)](/filings/0001628280-25-039904.md) | [(37.2)](/filings/0001628280-25-051737.md) | [(6.4) d](/filings/0001628280-26-049579.md) | [(1.7)](/filings/0001628280-26-035176.md) | [8.9](/filings/0001628280-26-056824.md) | [8.5](/filings/0001628280-25-051737.md) | [2.2 d](/filings/0001628280-26-049579.md) | [3.8](/filings/0001628280-26-035176.md) | [9.8](/filings/0001628280-26-056824.md) |
| Interest expense | $m | [11.2](/filings/0001628280-24-047866.md) | [11.1 d](/filings/0001628280-24-015334.md) | [10.9](/filings/0001628280-24-023626.md) | [7.6](/filings/0001628280-25-039904.md) | [11.4](/filings/0001628280-25-051737.md) | [10.3 d](/filings/0001628280-26-049579.md) | [12.7](/filings/0001628280-26-035176.md) | [12.8](/filings/0001628280-26-056824.md) | [12.8](/filings/0001628280-25-051737.md) | [12.6 d](/filings/0001628280-26-049579.md) | [12.3](/filings/0001628280-26-035176.md) | [12.9](/filings/0001628280-26-056824.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-047866.md) | not reported | [0.0](/filings/0001628280-25-025590.md) | [0.0](/filings/0001628280-25-039904.md) | [0.0](/filings/0001628280-25-051737.md) | not reported | [0.0](/filings/0001628280-26-035176.md) | [0.0](/filings/0001628280-26-056824.md) | [0.0](/filings/0001628280-25-051737.md) | [0.0 d](/filings/0001628280-26-049579.md) | [0.0](/filings/0001628280-26-035176.md) | [0.0](/filings/0001628280-26-056824.md) |
| Net income | $m | [(19.3)](/filings/0001628280-24-047866.md) | [(30.2) d](/filings/0001628280-25-015702.md) | [(2.5)](/filings/0001628280-25-025590.md) | [(8.6)](/filings/0001628280-25-039904.md) | [(53.5)](/filings/0001628280-25-051737.md) | [(5.9) d](/filings/0001628280-26-049579.md) | [(15.3)](/filings/0001628280-26-035176.md) | [(3.0)](/filings/0001628280-26-056824.md) | [(0.9)](/filings/0001628280-25-051737.md) | [(6.9) d](/filings/0001628280-26-049579.md) | [(2.9)](/filings/0001628280-26-035176.md) | [3.3](/filings/0001628280-26-056824.md) |
| Diluted EPS | $ per share | [(1.11)](/filings/0001628280-24-047866.md) | not reported | [(0.13)](/filings/0001628280-25-025590.md) | [(0.45)](/filings/0001628280-25-039904.md) | [(2.88)](/filings/0001628280-25-051737.md) | not reported | [(0.84)](/filings/0001628280-26-035176.md) | [(0.17)](/filings/0001628280-26-056824.md) | [(0.05)](/filings/0001628280-25-051737.md) | not reported | [(0.16)](/filings/0001628280-26-035176.md) | [0.15](/filings/0001628280-26-056824.md) |
| Basic EPS | $ per share | [(1.11)](/filings/0001628280-24-047866.md) | not reported | [(0.13)](/filings/0001628280-25-025590.md) | [(0.45)](/filings/0001628280-25-039904.md) | [(2.88)](/filings/0001628280-25-051737.md) | not reported | [(0.84)](/filings/0001628280-26-035176.md) | [(0.17)](/filings/0001628280-26-056824.md) | [(0.05)](/filings/0001628280-25-051737.md) | not reported | [(0.16)](/filings/0001628280-26-035176.md) | [0.18](/filings/0001628280-26-056824.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [154](/filings/0001628280-24-047866.md) | [141](/filings/0001628280-25-015702.md) | [121](/filings/0001628280-25-025590.md) | [117](/filings/0001628280-25-039904.md) | [114](/filings/0001628280-25-051737.md) | [72.8](/filings/0001628280-26-049579.md) | [61.9](/filings/0001628280-26-035176.md) | [53.5](/filings/0001628280-26-056824.md) | [53.6](/filings/0001628280-25-051737.md) | [54.8](/filings/0001628280-26-056824.md) | [50.0](/filings/0001628280-26-035176.md) | [44.7](/filings/0001628280-26-056824.md) |
| Current assets | $m | [229](/filings/0001628280-23-038677.md) | [203](/filings/0001628280-25-015702.md) | [178](/filings/0001628280-24-023626.md) | [179](/filings/0001628280-24-037238.md) | [173](/filings/0001628280-24-047866.md) | [136](/filings/0001628280-26-049579.md) | [126](/filings/0001628280-25-025590.md) | [119](/filings/0001628280-25-039904.md) | [125](/filings/0001628280-25-051737.md) | [116](/filings/0001628280-26-056824.md) | [111](/filings/0001628280-26-035176.md) | [114](/filings/0001628280-26-056824.md) |
| Total assets | $m | [940](/filings/0001628280-23-038677.md) | [895](/filings/0001628280-25-015702.md) | [868](/filings/0001628280-24-023626.md) | [858](/filings/0001628280-24-037238.md) | [807](/filings/0001628280-24-047866.md) | [898](/filings/0001628280-26-049579.md) | [878](/filings/0001628280-25-025590.md) | [863](/filings/0001628280-25-039904.md) | [857](/filings/0001628280-25-051737.md) | [837](/filings/0001628280-26-056824.md) | [824](/filings/0001628280-26-035176.md) | [818](/filings/0001628280-26-056824.md) |
| Current liabilities | $m | [81.8](/filings/0001628280-23-038677.md) | [71.7](/filings/0001628280-25-015702.md) | [53.2](/filings/0001628280-24-023626.md) | [53.8](/filings/0001628280-24-037238.md) | [62.8](/filings/0001628280-24-047866.md) | [59.6](/filings/0001628280-26-049579.md) | [59.4](/filings/0001628280-25-025590.md) | [239](/filings/0001628280-25-039904.md) | [247](/filings/0001628280-25-051737.md) | [239](/filings/0001628280-26-056824.md) | [231](/filings/0001628280-26-035176.md) | [289](/filings/0001628280-26-056824.md) |
| Total liabilities | $m | [696](/filings/0001628280-23-038677.md) | [680](/filings/0001628280-25-015702.md) | [655](/filings/0001628280-24-023626.md) | [654](/filings/0001628280-24-037238.md) | [655](/filings/0001628280-24-047866.md) | [752](/filings/0001628280-26-049579.md) | [747](/filings/0001628280-25-025590.md) | [735](/filings/0001628280-25-039904.md) | [730](/filings/0001628280-25-051737.md) | [716](/filings/0001628280-26-056824.md) | [705](/filings/0001628280-26-035176.md) | [695](/filings/0001628280-26-056824.md) |
| Long-term debt | $m | [600](/filings/0001628280-23-038677.md) | [591](/filings/0001628280-25-015702.md) | [585](/filings/0001628280-24-023626.md) | [584](/filings/0001628280-24-037238.md) | [577](/filings/0001628280-24-047866.md) | [677](/filings/0001628280-26-049579.md) | [672](/filings/0001628280-25-025590.md) | [479](/filings/0001628280-25-039904.md) | [467](/filings/0001628280-25-051737.md) | [463](/filings/0001628280-26-056824.md) | [460](/filings/0001628280-26-035176.md) | [393](/filings/0001628280-26-056824.md) |
| Current portion of debt | $m | [27.7](/filings/0001628280-23-038677.md) | [27.9](/filings/0001628280-25-015702.md) | [28.2](/filings/0001628280-24-023626.md) | [28.4](/filings/0001628280-24-037238.md) | [28.4](/filings/0001628280-24-047866.md) | [28.3](/filings/0001628280-26-049579.md) | [28.3](/filings/0001628280-25-025590.md) | [216](/filings/0001628280-25-039904.md) | [218](/filings/0001628280-25-051737.md) | [214](/filings/0001628280-26-056824.md) | [208](/filings/0001628280-26-035176.md) | [270](/filings/0001628280-26-056824.md) |
| Shareholders' equity | $m | [244](/filings/0001628280-24-047866.md) | [215](/filings/0001628280-26-049579.md) | [213](/filings/0001628280-25-051737.md) | [205](/filings/0001628280-25-051737.md) | [152](/filings/0001628280-25-051737.md) | [144](/filings/0001628280-25-051737.md) | [131](/filings/0001628280-26-056824.md) | [125](/filings/0001628280-25-039904.md) | [125](/filings/0001628280-25-051737.md) | [119](/filings/0001628280-26-056824.md) | [117](/filings/0001628280-26-035176.md) | [120](/filings/0001628280-26-056824.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.3 d](/filings/0001628280-24-047866.md) | [(17.7) d](/filings/0001628280-25-015702.md) | [(22.2)](/filings/0001628280-25-025590.md) | [(5.1) d](/filings/0001628280-25-039904.md) | [(1.1) d](/filings/0001628280-25-051737.md) | [(13.5) d](/filings/0001628280-26-049579.md) | [(9.1)](/filings/0001628280-26-035176.md) | [(2.3) d](/filings/0001628280-26-056824.md) | [11.2 d](/filings/0001628280-25-051737.md) | [(3.3) d](/filings/0001628280-26-049579.md) | [(2.7)](/filings/0001628280-26-035176.md) | [(3.2) d](/filings/0001628280-26-056824.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001628280-24-047866.md) | [0.2 d](/filings/0001628280-25-015702.md) | [0.1](/filings/0001628280-25-025590.md) | [0.1 d](/filings/0001628280-25-039904.md) | [0.0 d](/filings/0001628280-25-051737.md) | [0.2 d](/filings/0001628280-26-049579.md) | [0.1](/filings/0001628280-26-035176.md) | [0.1 d](/filings/0001628280-26-056824.md) | [0.0 d](/filings/0001628280-25-051737.md) | [0.0 d](/filings/0001628280-26-049579.md) | [0.0](/filings/0001628280-26-035176.md) | [0.0 d](/filings/0001628280-26-056824.md) |
| Share repurchases | $m | [3.5 d](/filings/0001628280-24-047866.md) | not reported | not reported | not reported | [0.0 d](/filings/0001628280-24-047866.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.9](/filings/0001628280-23-038677.md) | [18.3](/filings/0001628280-24-023626.md) | [20.2](/filings/0001628280-24-037238.md) | [17.4](/filings/0001628280-24-047866.md) | [19.1](/filings/0001628280-25-025590.md) | [19.3](/filings/0001628280-25-039904.md) | [18.6](/filings/0001628280-25-051737.md) | [18.2](/filings/0001628280-26-035176.md) | [17.9](/filings/0001628280-26-056824.md) | [18.0](/filings/0001628280-25-051737.md) | [18.2](/filings/0001628280-26-035176.md) | [21.9](/filings/0001628280-26-056824.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,252,186 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056824.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.